Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.
- R. Cools, R. Barker, B. Sahakian, T. Robbins
- Medicine
- Cerebral cortex
- 1 December 2001
We investigated how dopamine (DA) systems contribute to cognitive performance in the domain of learning and attentional flexibility by examining effects of withdrawing DA-ergic medication in patients… Expand
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
- C. Williams-Gray, J. R. Evans, +8 authors R. Barker
- Psychology, Medicine
- Brain : a journal of neurology
- 1 November 2009
Cognitive abnormalities are common in Parkinson's disease, with important social and economic implications. Factors influencing their evolution remain unclear but are crucial to the development of… Expand
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
- A. Kehagia, R. Barker, T. Robbins
- Psychology, Medicine
- The Lancet Neurology
- 1 December 2010
Cognitive impairment in patients with Parkinson's disease is gaining increased clinical significance owing to the relative success of therapeutic approaches to the motor symptoms of this disorder.… Expand
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
- C. Williams-Gray, T. Foltynie, C. Brayne, T. Robbins, R. Barker
- Psychology, Medicine
- Brain : a journal of neurology
- 1 July 2007
We have previously performed detailed clinical and neuropsychological assessments in a community-based cohort of patients with newly diagnosed parkinsonism, and through analysis of a subcohort with… Expand
RNA velocity of single cells
- G. L. Manno, R. Soldatov, +20 authors P. Kharchenko
- Biology, Computer Science
- Nature
- 24 July 2018
TLDR
Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's Disease
- A. J. Morton, N. Wood, M. Hastings, C. Hurelbrink, R. Barker, E. Maywood
- Biology, Medicine
- The Journal of Neuroscience
- 5 January 2005
Sleep disturbances in neurological disorders have a devastating impact on patient and carer alike. However, their pathological origin is unknown. Here we show that patients with Huntington's disease… Expand
Mechanisms of cognitive set flexibility in Parkinson's disease.
- R. Cools, R. Barker, B. Sahakian, T. Robbins
- Psychology, Medicine
- Brain : a journal of neurology
- 1 December 2001
Previous research on cognitive set shifting in patients with Parkinson's disease has often been confounded by concept formation, rule learning, working memory and/or general slowing of cognitive… Expand
A pathophysiological model of freezing of gait in Parkinson's disease.
Freezing of gait (FOG) is a common phenomenon in Parkinson's disease (PD) affecting over half of those in the advanced stages of the disease and often does not respond to standard drug therapies.… Expand
L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
- R. Cools, S. Lewis, L. Clark, R. Barker, T. Robbins
- Psychology, Medicine
- Neuropsychopharmacology
- 2007
Evidence indicates that dopaminergic medication in Parkinson's disease may impair certain aspects of cognitive function, such as reversal learning. We used functional magnetic resonance imaging in… Expand
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
- R. Cools, E. Stefanova, R. Barker, T. Robbins, A. Owen
- Psychology, Medicine
- Brain : a journal of neurology
- 1 March 2002
This study examined the effects of L-dopa medication in patients with Parkinson's disease on cortical and subcortical blood flow changes during two tasks known to involve frontostriatal circuitry.… Expand